4.7 Article

NLRP3 activation induces ASC-dependent programmed necrotic cell death, which leads to neutrophilic inflammation

Journal

CELL DEATH & DISEASE
Volume 4, Issue -, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/cddis.2013.169

Keywords

NLRP3; inflammasome; CAPS; programmed necrotic cell death; IL-1 beta; neutrophil

Categories

Funding

  1. MEXT
  2. Ministry of Health, Labour and Welfare, Japan
  3. Grants-in-Aid for Scientific Research [23659543, 23390280, 24791136] Funding Source: KAKEN

Ask authors/readers for more resources

NLR family pyrin domain containing 3 (NLRP3) is a cytoplasmic pattern recognition receptor that regulates innate immune responses by forming a protein complex, the inflammasome. It leads to production of proinflammatory cytokine productions such as interleukin 1 beta (IL-1 beta). We and others demonstrated that an induction of activated NLRP3 also induced cell death. However, little is known about the characteristics and mechanisms of the cell death and its involvement in the pathogenesis of inflammatory conditions. In this study, we established cell lines in which NLRP3 was induced by doxycycline using a tetracycline-inducible expression (Tet-on) system. Using this system, the expression of NLRP3 mutants in cryopyrin-associated periodic syndrome (CAPS) patients was sufficient for the induction of necrotic cell death without lipopolysaccharide stimulation or generation of mature IL-1 beta. We also found that CA074-Me, a cathepsin B inhibitor, blocked cell death before oligomerization of apoptosis-associated speck-like protein containing a CARD (ASC), whereas Z-VAD-fmk, a pan-caspase inhibitor, blocked the cell death after the oligomerization. Silencing of the ASC gene (Pycard) by small hairpin RNA treatment inhibited the NLRP3 mutant-induced cell death, but silencing of the caspase-1 gene (Casp1) did not. Taken together, these results indicated that ASC was indispensable for NLRP3-mediated programmed necrotic cell death, and that this type of cell death was distinct from 'pyroptosis', which requires caspase-1. Finally, we demonstrated in an in vivo model that the programmed necrotic cell death induced by activated NLRP3 could cause neutrophil infiltration, indicating a possible role of cell death in neutrophil infiltration of skin lesions in CAPS patients.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Dermatology

Inducible skin-associated lymphoid tissue (iSALT) in a patient with Schnitzler syndrome who manifested wheals on recurrent localized erythema

H. Kamido, D. Shimomiya, T. Kogame, R. Takimoto-Ito, T. R. Kataoka, M. Hirata, C. Ueshima, A. Otsuka, F. M. Ghazawi, T. Nomura, N. Kambe, K. Kabashima

BRITISH JOURNAL OF DERMATOLOGY (2021)

Letter Dermatology

Skin-associated lymphoid tissue could be a sign of systemic disease: reply from authors

T. Kogame, N. Kambe, R. Takimoto-Ito, T. Nomura, K. Kabashima

BRITISH JOURNAL OF DERMATOLOGY (2021)

Review Pharmacology & Pharmacy

Advances in the pathophysiology of atopic dermatitis revealed by novel therapeutics and clinical trials

Xiaoliang Yang, Naotomo Kambe, Riko Takimoto-Ito, Kenji Kabashima

Summary: AD is an inflammatory skin disease influenced by genetics, immune response, and environment. Therapies like dupilumab, crisaborole, and delgocitinib provide hope for effective treatment, and offer insight into the pathophysiology of AD.

PHARMACOLOGY & THERAPEUTICS (2021)

Article Pediatrics

NOD2 Mutation-Associated Case with Blau Syndrome Triggered by BCG Vaccination

Akiko Arakawa, Naotomo Kambe, Ryuta Nishikomori, Akiyo Tanabe, Masamichi Ueda, Chikako Nishigori, Yoshiki Miyachi, Nobuo Kanazawa

Summary: In this case report, a patient developed sporadic Blau syndrome after BCG vaccination, with a functional mutation in NOD2 detected through genetic analysis. This suggests that BCG vaccination may trigger granuloma formation in Blau syndrome patients with such genetic background.

CHILDREN-BASEL (2021)

Article Pediatrics

Sustained Surface ICAM-1 Expression and Transient PDGF-B Production by Phorbol Myristate Acetate-Activated THP-1 Cells Harboring Blau Syndrome-Associated NOD2 Mutations

Mizuho Nishiyama, Hong-jin Li, Ikuo Okafuji, Akihiko Fujisawa, Mizue Ehara, Naotomo Kambe, Fukumi Furukawa, Nobuo Kanazawa

Summary: In Blau syndrome patients, ICAM-1 and PDGF-B were positively immunostained in NOD2-expressing giant cells in the granulomatous skin lesion, suggesting that newly differentiating macrophages harboring mutant NOD2 may play a role in granuloma formation in Blau syndrome, possibly related to sustained surface ICAM-1 expression and transient PDGF-B production.

CHILDREN-BASEL (2021)

Article Allergy

Anti-TNF treatment corrects IFN-γ-dependent proinflammatory signatures in Blau syndrome patient-derived macrophages

Yohko Kitagawa, Yuri Kawasaki, Yuichi Yamasaki, Naotomo Kambe, Syuji Takei, Megumu K. Saito

Summary: IFN-gamma stimulation plays a key role in driving aberrant inflammatory responses in BS-associated macrophages. However, long-term treatment with anti-TNF agents can ameliorate these abnormalities, suggesting a prerequisite role of TNF or similar cytokines in inducing proinflammatory signaling during macrophage development in BS patients.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

Letter Dermatology

Acquired idiopathic generalized anhidrosis following pembrolizumab treatment

K. Furuta, A. Horiguchi, Y. Nakagawa, N. Kambe, T. Kogame

CLINICAL AND EXPERIMENTAL DERMATOLOGY (2022)

Article Dermatology

A New Era with the Development of Cytokine-Based Therapy for Pruritus

Rintaro Shibuya, Riko Takimoto-Ito, Naotomo Kambe, Kenji Kabashima

Summary: Pruritus, a common dermatological condition, can significantly impact quality of life. Traditional antipruritic drugs may be ineffective, but recent advancements in molecularly targeted drugs have shown promising results in improving itching without the need for steroids. Understanding the cytokine-mediated mechanism of pruritus is crucial for guiding better therapies.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)

Letter Dermatology

Interleukin-13 inhibition by tralokinumab reduces inducible T-cell costimulator-positive innate lymphoid cells in skin lesions of atopic dermatitis

Toshiaki Kogame, Satoru Yonekura, Paola Lovato, Masahiro Hirata, Riko Takimoto-ito, Tomoya Takegami, Takayoshi Komatsu-Fujii, Naotomo Kambe, Takashi Nomura, Mads A. Ropke, Kenji Kabashima

Summary: Despite the limited sample size and low frequency of skin ILCs in this study, the data suggest that ICOS+ ILCs express IL-13Ra1 and that the density of ICOS+ ILCs decreases after four weeks of tralokinumab treatment.

BRITISH JOURNAL OF DERMATOLOGY (2023)

Letter Dermatology

A case of Kimura disease with atopic dermatitis successfully treated with baricitinib

Marina Ueda, Toshiaki Kogame, Gyohei Egawa, Naotomo Kambe, Kenji Kabashima

JOURNAL OF DERMATOLOGY (2023)

Article Allergy

Summary of the current status of clinically diagnosed cases of Schnitzler syndrome in Japan

Riko Takimoto-Ito, Naotomo Kambe, Toshiaki Kogame, Takashi Nomura, Kazushi Izawa, Tomoyasu Jo, Yasuhiro Kazuma, Hajime Yoshifuji, Yuya Tabuchi, Hiroyasu Abe, Mayuko Yamamoto, Kimiko Nakajima, Ozumi Tomita, Yosuke Yagi, Kazumoto Katagiri, Yuki Matsuzaka, Yohei Takeuchi, Miho Hatanaka, Takuro Kanekura, Sora Takeuchi, Takafumi Kadono, Yuya Fujita, Kiyoshi Migita, Takahiro Fujino, Takahiko Akagi, Tomoyuki Mukai, Tohru Nagano, Mitsuhiro Kawano, Hayato Kimura, Yukari Okubo, Akimichi Morita, Michihiro Hide, Takahiro Satoh, Akihiko Asahina, Nobuo Kanazawa, Kenji Kabashima

Summary: Schnitzler syndrome is a rare disorder characterized by chronic urticaria. A nationwide survey was conducted in Japan to determine the current status of the disease. Clinical information of 36 diagnosed cases was collected, providing insights into the clinical features and treatment of the syndrome. Continuous collection and long-term follow-up of clinical information are crucial for the appropriate management and further understanding of Schnitzler syndrome.

ALLERGOLOGY INTERNATIONAL (2023)

Letter Dermatology

A case of post herpes zoster granulomatous dermatitis successfully treated with UVA1 phototherapy

Atsushi Naito, Toshiaki Kogame, Naotomo Kambe, Kenji Kabashima

JOURNAL OF DERMATOLOGY (2023)

Article Dermatology

Neutrophilic epitheliotropism, proposed as an auto-inflammatory condition of neutrophilic urticarial dermatosis including Schnitzler syndrome, is also observed in Japanese cases

Hitomi Nakaizumi, Naotomo Kambe, Hiroyuki Irie, Yo Kaku, Masakazu Fujimoto, Hajime Yoshifuji, Yasuhiro Kazuma, Kazumoto Katagiri, Takuro Kanekura, Kenji Kabashima

Summary: Schnitzler syndrome (SchS) is a rare autoinflammatory disease characterized by bone pain, recurrent fever, and other symptoms. A key feature of the syndrome is the presence of a persistent urticarial-like rash. Histopathological data suggests that neutrophilic epitheliotropism, or the tendency of neutrophils to infiltrate and affect epithelial tissue, can be a useful marker for diagnosing SchS and differentiating it from conventional urticaria. Understanding this characteristic is crucial for early diagnosis and appropriate treatment.

JOURNAL OF DERMATOLOGY (2023)

Review Allergy

Panniculitis in dermatomyositis: Two cases with antitranscriptional intermediary factor-1 antibody as myositis-specific antibody and review of the literature

Kaori Takezawa, Ikuko Ueda-Hayakawa, Akihiro Tanaka, Yonsu Son, Fumikazu Yamazaki, Naotomo Kambe, Hiroyuki Okamoto, Manabu Fujimoto

Summary: This article describes the clinical features of two patients with DM-associated panniculitis and anti-TIF1 antibodies, and reviews 23 cases of panniculitis in DM patients with detailed information on autoantibodies. Female predominance and the presence of anti-MDA5 and anti-TIF1 antibodies were observed. Further case accumulation is needed to understand the relationship between panniculitis and autoantibodies.

JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY (2022)

Letter Allergy

Hereditary angioedema with a novel mutation, c.1481G>C, in the SERPING1 gene

Riko Takimoto-Ito, Naotomo Kambe, Kazushi Izawa, Takahiro Yasumi, Kenji Kabashima

Summary: Hereditary angioedema (HAE) is an autosomal dominant genetic disease characterized by recurrent cutaneous and submucosal swelling caused by mutations in the SERPING1 gene. A Japanese case of HAE with a novel mutation in the SERPING1 gene was reported, which may contribute to understanding the pathogenesis of HAE and the development of effective treatments.

JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY (2021)

No Data Available